Sicagen India Limited has intimated BSE Limited about a scheduled meeting of its Board of Directors.
The Board meeting is scheduled to be held on Monday, 24 November 2026. The primary agenda for this meeting is to consider and approve the company's Un-audited Financial Results for both Standalone and Consolidated operations. These results are for the Quarter and Half year ended 30 September 2026.
The company reiterates its earlier communication regarding the closure of the trading window for dealing in the company's equity shares. As per the letter dated 28 September 2026, the trading window for Designated Persons and their immediate relatives has been closed since 1 October 2026. This closure will remain in effect until 48 hours after the declaration of the aforementioned Un-audited Financial Results. This measure is in compliance with the company's internal Code of Conduct to regulate, monitor, and report trading by insiders, which is framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.